BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 19401787)

  • 1. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
    Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
    Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-dose tacrolimus coadministered with raloxifene on the skeletal system in male rats.
    Folwarczna J; Kaczmarczyk-Sedlak I; Pytlik M; Nowińska B; Cegieła U; Sliwiński L; Janiec W; Trzeciak H; Trzeciak HI
    Acta Pol Pharm; 2009; 66(2):207-12. PubMed ID: 19719057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice.
    García-Pérez MA; Noguera R; del Val R; Noguera I; Hermenegildo C; Cano A
    Fertil Steril; 2006 Oct; 86(4):1003-5. PubMed ID: 16963036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
    Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW
    J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.
    Onoe Y; Miyaura C; Ito M; Ohta H; Nozawa S; Suda T
    J Bone Miner Res; 2000 Mar; 15(3):541-9. PubMed ID: 10750569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
    Power KA; Ward WE; Chen JM; Saarinen NM; Thompson LU
    Bone; 2006 Jul; 39(1):117-24. PubMed ID: 16469549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats.
    Phrakonkham P; Chevalier J; Desmetz C; Pinnert MF; Bergès R; Jover E; Davicco MJ; Bennetau-Pelissero C; Coxam V; Artur Y; Canivenc-Lavier MC
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):105-15. PubMed ID: 17655901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats.
    Ammann P; Bourrin S; Brunner F; Meyer JM; Clément-Lacroix P; Baron R; Gaillard M; Rizzoli R
    Bone; 2004 Jul; 35(1):153-61. PubMed ID: 15207751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activation of gene transcription via oestrogen response elements by a raloxifene analogue.
    Engdahl C; Jochems C; Gustafsson JA; van der Saag PT; Carlsten H; Lagerquist MK
    J Endocrinol; 2009 Dec; 203(3):349-56. PubMed ID: 19752149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo.
    Somjen D; Katzburg S; Kohen F; Gayer B; Livne E
    J Cell Biochem; 2008 Apr; 103(6):1826-32. PubMed ID: 18059016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray.
    Pie JE; Park JH; Park YH; Ryu YM; Kim KN; Suh SW; Becker KG; Cho-Chung YS; Kim MK
    J Nutr Biochem; 2006 Mar; 17(3):157-64. PubMed ID: 16169203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro.
    Sliwiński L; Folwarczna J; Janiec W; Grynkiewicz G; Kuzyk K
    Pharmacol Rep; 2005; 57(3):352-9. PubMed ID: 15985718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs.
    Somjen D; Shen M; Stern N; Mirsky N
    J Cell Biochem; 2006 Sep; 99(1):133-9. PubMed ID: 16598752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomechanical and histological outcome of combined raloxifene-estrogen therapy on skeletal and reproductive tissues.
    Tasci A; Bilgili H; Altunay H; Gecit MR; Keskin D
    Eur J Pharmacol; 2010 Feb; 627(1-3):354-61. PubMed ID: 19903467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.